Pharmafile Logo
Pharmafocus logo
Advanced Search

R&D

Showing 15 posts of 146 posts found.

Brain image

The brain drain

April 5, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, R&D, brain drain, research and development

Concerns about the growing number of companies disinvesting from neuroscience research have been growing in recent years, and the latest …

Feature

Early-stage research gains another funding boost

March 23, 2012
Research and Development, Sales and Marketing GSK, Index Ventures, Janssen, R&D

GlaxoSmithKline and Janssen are among the key investors in a venture capital fund aimed solely at identifying promising pharma start-ups.  …

News
AstraZeneca image

AstraZeneca pulls depression drug, takes $50m hit

March 20, 2012
Research and Development, Sales and Marketing AstraZeneca, R&D, depression, failure, pipeline

AstraZeneca and partner Targacept will not file their depression drug TC-5214 for regulatory review. The decision comes after disappointing Phase …

News

AstraZeneca touting for business at partnering conference

March 19, 2012
Research and Development, Sales and Marketing AstraZeneca, Bio-Europe, R&D, partnering

AstraZeneca is marketing itself as a key partner for drug development deals, ahead of a European partnering conference.  The Bio-Europe …

News
Jon Tucker and David Willetts picture

Science minister opens new Pfizer facility in Havant

March 13, 2012
Manufacturing and Production Havant, Pfizer, R&D, Tucker, Willetts

Science minister David Willetts has opened Pfizer’s new state-of-the-art cold storage facility at its site in Havant.  The new £7 …

News

GSK expands apprenticeship programme

March 13, 2012
Manufacturing and Production, Research and Development GSK, Hayes, R&D, manufacturing

GlaxoSmithKline has expanded its apprenticeship programme with the creation of positions spanning manufacturing, IT, and R&D.  The multi-disciplinary scheme is …

News
Lilly scientists

Academic alliances to speed Lilly’s R&D

March 1, 2012
Research and Development, Sales and Marketing R&D, academia, break through drugs, collaboration, lilly

Lilly has unveiled a range of collaborations with academic researchers which it says will help it discover and develop more …

News
Biogen image

Biogen to pay $563 million for Stromedix

February 15, 2012
Research and Development, Sales and Marketing Bioden Idec, R&D, STX-100, Stromedix

Biogen Idec will acquire the specialist immunology firm Stromedix for around $500 million. Biogen currently focuses on the development of …

News
GSK picture

GSK posts strong underlying sales growth

February 8, 2012
Research and Development, Sales and Marketing Avodart, GSK, R&D, Seretide, Witty, rotarix

GlaxoSmithKline has posted strong underlying growth for 2011, but warns of a tough year ahead.  The UK firm saw 4% …

News
AstraZeneca picture

AstraZeneca to cut 7,300 jobs as growth stalls

February 2, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, David Brennan, R&D

AstraZeneca will make 7,300 cuts to its sales and R&D staff by 2014, but the company has not yet said …

News
Lilly HQ picture

Amylin to pay up to $1.6 billion to sever ties with Lilly

November 8, 2011
Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, R&D, lilly

Amylin will pay up to $1.6 billion to end its diabetes pact with Lilly after a difficult year for the …

News

UK pharma downbeat on its future – survey

November 8, 2011
Research and Development ABPI, R&D, VBP, rsa

The impacts of NHS reform and the increasingly high cost of R&D is causing pharma to doubt its future in …

News
david_roblin__picture_o

Ex-Pfizer R&D head Dr David Roblin joins Destiny Pharma

November 7, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Destiny Pharma, Pfizer, R&D

Anti-microbial drug developers Destiny Pharma have appointed Dr David Roblin as its new medical director. Dr Roblin was formerly head …

Appointment
picture_2

Lundbeck appoints two new R&D vice presidents

November 1, 2011
Research and Development Lundbeck, R&D

Lundbeck has appointed Jens Peter Balling and Iman Barilero as vice presidents of its research and development organisation. The new …

Appointment
Lab image

Does drug development deliver on its promises?

October 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, R&D

I am always guided by the motto of the Royal Society, ‘Nullius in Verba’. This means, with typical Latin brevity: …

Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026